1,346
Views
9
CrossRef citations to date
0
Altmetric
Research Articles

Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications

, ORCID Icon, , , ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 9543-9567 | Received 16 Dec 2020, Accepted 10 May 2021, Published online: 01 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Mohanad A. Mahgoub, Ahmed Alnaem, Mohammed Fadlelmola, Mazin Abo-idris, Alaa A. Makki, Abdelgadir A. Abdelgadir & Abdulrahim A. Alzain. (2023) Discovery of novel potential inhibitors of TMPRSS2 and Mpro of SARS‐CoV‐2 using E-pharmacophore and docking-based virtual screening combined with molecular dynamic and quantum mechanics. Journal of Biomolecular Structure and Dynamics 41:14, pages 6775-6788.
Read now
Biswajit Naik, Nidhi Gupta, Priya Godara, Varshita Srivastava, Prateek Kumar, Rajanish Giri, Vijay Kumar Prajapati, Kailash C. Pandey & Dhaneswar Prusty. (2023) Structure-based virtual screening approach reveals natural multi-target compounds for the development of antimalarial drugs to combat drug resistance. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-25.
Read now
Manisha Pritam, Somenath Dutta, Krishna Mohan Medicherla, Rajnish Kumar & Satarudra Prakash Singh. (2023) Computational analysis of spike protein of SARS-CoV-2 (Omicron variant) for development of peptide-based therapeutics and diagnostics. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-19.
Read now

Articles from other publishers (6)

Satyendra Singh, Ketan Kumar, Mamta Panda, Aryan Srivastava, Amit Mishra & Vijay Kumar Prajapati. (2022) High-throughput virtual screening of small-molecule inhibitors targeting immune cell checkpoints to discover new immunotherapeutics for human diseases. Molecular Diversity 27:2, pages 729-751.
Crossref
Satyendra Singh, Priya Chauhan, Vinita Sharma, Abhishek Rao, Bajarang Vasant Kumbhar & Vijay Kumar Prajapati. (2022) Identification of multi-targeting natural antiviral peptides to impede SARS-CoV-2 infection. Structural Chemistry.
Crossref
Mamta Panda, Elora Kalita, Satyendra Singh, Ketan Kumar & Vijay Kumar Prajapati. (2022) Nanobody-peptide-conjugate (NPC) for passive immunotherapy against SARS-CoV-2 variants of concern (VoC): a prospective pan-coronavirus therapeutics. Molecular Diversity.
Crossref
Satyendra Singh & Vijay Kumar Prajapati. (2022) Exploring actinomycetes natural products to identify potential multi-target inhibitors against Leishmania donovani. 3 Biotech 12:9.
Crossref
Swati Singh, Hemanth Naick Banavath, Priya Godara, Biswajit Naik, Varshita Srivastava & Dhaneswar Prusty. (2022) Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach. 3 Biotech 12:9.
Crossref
Priya Chouhan, Satyendra Singh, Vinita Sharma & Vijay Kumar Prajapati. (2022) Anti-IL-10 Antibody Humanization by SDR Grafting with Enhanced Affinity to Neutralize the Adverse Response of Interleukin-10. International Journal of Peptide Research and Therapeutics 28:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.